Safety study of an experimental antibody in healthy men
This early-phase trial tests a new antibody-based therapy called SCTB10 in healthy volunteers to see if it's safe and how the body processes it. Participation can help determine the right dose for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a male aged 18 to 50 years old.
- Your weight and height must fall within a specific healthy range (body mass index 19–26).
- You must be generally healthy, with no significant heart, blood, or allergy conditions.
- You agree to use effective birth control during the study and for 6 months after the last dose.
- You cannot have taken any prescription or over-the-counter drugs or supplements in the last 2 weeks.
- You cannot have received any biologic therapy (like antibody treatments) in the last 16 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new antibody-based drug in healthy volunteers to see how safe it is and how the body handles it. Participants will receive a single injection and be monitored closely for a few months.
This study tests a new antibody medicine for people with COVID-19 who are at high risk of getting very sick. If you qualify, you would receive the study drug or a placebo (inactive substance) to see if it helps you recover without needing to go to the hospital.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This trial tests a new antibody drug called CM583 in healthy people to see if it is safe and how the body handles it. It may help treat conditions related to certain proteins involved in pain and inflammation.
This trial tests a new medicine called TRT-448 in healthy adults to see if it is safe and how the body processes it. It is a first-in-human study, meaning the drug has not been given to people before.
This trial tests a new medicine in healthy people to see how safe it is and how the body handles it. It may help pave the way for future treatments.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.